Jacob Steven Leach insider trades
Open-market stock purchases and sales by Jacob Steven Leach, President, CEO, and Director at DexCom Inc, from SEC Form 4 filings since Mar 9, 2017.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +28%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 22, 2026 | DXCM DexCom Inc | Sold (not open market) | $134K |
| Jun 15, 2026 | SNES SenesTech, Inc | Bought (not open market) | — |
| May 22, 2026 | DXCM DexCom Inc | Sold (not open market) | $104K |
| Mar 8, 2026 | DXCM DexCom Inc | Bought (not open market) | — |
| Mar 8, 2026 | DXCM DexCom Inc | Sold (not open market) | $1.3M |
| Jan 29, 2026 | DXCM DexCom Inc | Sold (not open market) | $224K |
| Jan 29, 2026 | DXCM DexCom Inc | Bought (not open market) | — |
| Nov 18, 2025 | SNES SenesTech, Inc | Sold | $168 |
| Nov 10, 2025 | DXCM DexCom Inc | Bought | $863K |
| Nov 10, 2025 | DXCM DexCom Inc | Bought | $139K |